Capital Flow Monitor · Sponsors · CIK 1544227
Tempest Therapeutics, Inc.
2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE, CA, 94005 · 415-798-8589
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$4.1M
Sold
$4.1M
% sold
100.0%
Investors
1
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | D ·current | 506(b) | $4.1M | $4.1M | 100.0% | 1 | EDGAR ↗ |
| 2026-04-03 | D | 506(b) | $2.0M | $2.0M | 100.0% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Matthew Angel — Executive Officer / Director, Brisbane, CA
1 other raise
- Factor Bioscience LLC $1.0M of $5.0M · 20.0%
- Justin Trojanowski — Executive Officer, Brisbane, CA
- John David Yee — Director, Brisbane, CA
- William Drake Richey — Director, Brisbane, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.